E
Erik Barr
Researcher at University of Maryland, College Park
Publications - 39
Citations - 1308
Erik Barr is an academic researcher from University of Maryland, College Park. The author has contributed to research in topics: Randomized controlled trial & Population. The author has an hindex of 13, co-authored 35 publications receiving 1024 citations. Previous affiliations of Erik Barr include University of Maryland Medical Center & University of Maryland, Baltimore.
Papers
More filters
Journal ArticleDOI
Cluster-randomized trial of a mobile phone personalized behavioral intervention for blood glucose control.
Charlene C. Quinn,Michelle Shardell,Michael L. Terrin,Erik Barr,Shoshana H. Ballew,Ann L. Gruber-Baldini +5 more
TL;DR: The combination of behavioral mobile coaching with blood glucose data, lifestyle behaviors, and patient self-management data individually analyzed and presented with evidence-based guidelines to providers substantially reduced glycated hemoglobin levels over 1 year.
Journal ArticleDOI
Cluster-randomized trial of a mobile phone personalized behavioral intervention for blood glucose control. Diabetes Care 2011;34:1934–1942
Charlene C. Quinn,Shardell,Michael L. Terrin,Erik Barr,Shoshana H. Ballew,Ann L. Gruber-Baldini +5 more
TL;DR: In the article listed above, the values for the 9-month glycated hemoglobins are incorrect due to a programming error.
Journal ArticleDOI
Mobile diabetes intervention study: testing a personalized treatment/behavioral communication intervention for blood glucose control.
Charlene C. Quinn,Ann L. Gruber-Baldini,Michelle Shardell,Kelly Weed,Suzanne Sysko Clough,Malinda Peeples,Michael L. Terrin,Lauren Bronich-Hall,Erik Barr,Dan Lender +9 more
TL;DR: Traditional methods of disease management have not achieved adequate control for BG and other conditions important to persons with diabetes, and tools to improve communication between patients and PCPs may improve patient outcomes and be satisfactory to patients and physicians.
Journal ArticleDOI
Mobile Diabetes Intervention for Glycemic Control in 45- to 64-Year-Old Persons With Type 2 Diabetes.
Charlene C. Quinn,Michelle Shardell,Michael L. Terrin,Erik Barr,DoHwan Park,Faraz Shaikh,Jack M. Guralnik,Ann L. Gruber-Baldini +7 more
TL;DR: The mobile health intervention was as effective at managing Type 2 diabetes in older adults as younger persons and resulted in greater 12-month declines in HbA1c, compared with usual care.
Journal ArticleDOI
Belatacept for renal rescue in lung transplant patients
I. Timofte,Michael L. Terrin,Erik Barr,Pablo G. Sanchez,June Kim,Robert M. Reed,E. Britt,Bharath Ravichandran,Keshava Rajagopal,Bartley P. Griffith,Si M. Pham,Richard N. Pierson,Aldo Iacono +12 more
TL;DR: Belatacept use appears to permit safe transient reduction in conventional immunosuppressive therapy and was associated with stable or improved renal function in a small retrospective series of lung transplant recipients with acute or chronic renal insufficiency.